Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy. | Curr Med Chem;13(15): 1839-43, 2006. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy.

Guertin, Kevin R; Grimsby, Joseph.

Affiliation

Guertin KR; Department of Discovery Chemistry, Roche Research Center, 340 Kingsland St., Nutley, New Jersey 07110, USA. kevin.guertin@roche.com

Curr Med Chem ; 13(15): 1839-43, 2006.

Article in En | MEDLINE | ID: mdl-16787225

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Enzyme Activators / Diabetes Mellitus, Type 2 / Glucokinase Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2006 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Enzyme Activators / Diabetes Mellitus, Type 2 / Glucokinase Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2006 Document type: Article Affiliation country: Country of publication: